The AlphaLISA™ immunoassay kit for human transthyretin enables the quantitative determination of human transthyretin (TTR) in buffer, serum, cell culture media, and cell lysates using a homogeneous AlphaLISA assay (no wash steps).
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein Quantification |
Dynamic Range | 14.5 - 100,000 pg/mL |
Limit of Detection | 14.5 pg/mL |
Limit of Quantification | 47.6 pg/mL |
Sample Volume | 10 µL |
The AlphaLISA™ immunoassay kit for human transthyretin enables the quantitative determination of human transthyretin (TTR) in buffer, serum, cell culture media, and cell lysates using a homogeneous AlphaLISA assay (no wash steps).
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Formats:
AlphaLISA features:
AlphaLISA technology allows the detection of molecules of interest in buffer, cell culture media, serum and plasma in a highly sensitive, quantitative, reproducible and user-friendly mode. In an AlphaLISA assay, a Biotinylated Anti-Analyte Antibody binds to the Streptavidin-coated Alpha Donor beads, while another Anti-Analyte Antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Transthyretin (TTR) is a transport protein in serum and CSF, most notably know for transporting thyroxine (T4) and retinol binding protein. TTR is produced in the liver where it is secreted into the blood. CSF TTR is produced in the choroid plexus. Misfolding and aggregation of TTR has be linked to amyloid diseases. Drugs have been designed to stabilize TTR and prevent mis aggregation.
Application |
Protein Quantification
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Modality |
Alpha
|
Dynamic Range |
14.5 - 100,000 pg/mL
|
Limit of Detection |
14.5 pg/mL
|
Limit of Quantification |
47.6 pg/mL
|
Product Group |
Kit
|
Sample Volume |
10 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
Transthyretin
|
Target Class |
Biomarkers
|
Target Species |
Human
|
Technology |
Alpha
|
Unit Size |
100 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
We are here to answer your questions.